Abdominal Surgery in Crohn’s Disease: Risk Factors for Complications

Introduction: Abdominal surgery in patients with Crohn’s disease (CD) is challenging, especially in the biologic era. The aim of this study was to evaluate factors associated with increased risk for postoperative complications in CD. Methods: A retrospective study was conducted with consecutive patients who underwent abdominal surgery for CD from January 2012 to January 2018. Results: Of 103 patients, 32% had postoperative complications. Gender, age, disease location and phenotype, hemoglobin and albumin levels, previous abdominal surgery, and preoperative optimization did not differ between the groups with or without complications. Thirty-five percent of the patients were under anti-TNF therapy, and this medication was not associated with increased risk for postoperative complications. Time since the onset of the disease was significantly higher in patients with complications (12.9 vs. 9.4, p = 0.04). In multivariate analysis, creation of ostomy and urgent surgery were the only variables independently associated with increased risk for complications (OR 3.2, 95% CI 1.12–9.46 and OR 2.94, 95% CI 0.98–9.09, respectively). Conclusion: Urgent surgery for CD should preferably be performed in specialized centers, and creation of stoma is not necessarily associated with lower rate of postoperative complications but rather less severe complications.

[1]  S. Steele,et al.  When should we add a diverting loop ileostomy to laparoscopic ileocolic resection for primary Crohn’s disease? , 2020, Surgical Endoscopy.

[2]  G. Fiorino,et al.  The trend of C-Reactive protein allows a safe early discharge after surgery for Crohn’s disease , 2020, Updates in Surgery.

[3]  F. Cianchi,et al.  Laparoscopic ileo-colic resection and right hemicolectomy for Crohn’s disease and colon cancer: a preliminary comparative study on post-operative outcome , 2020, Updates in Surgery.

[4]  E. Vicaut,et al.  Postoperative morbidity after iterative ileocolonic resection for Crohn's Disease: should we be worried? A prospective multicentric cohort study of the GETAID Chirurgie. , 2019, Journal of Crohn's & colitis.

[5]  V. Celentano,et al.  High risk of septic complications following surgery for Crohn's disease in patients with preoperative anaemia, hypoalbuminemia and high CRP , 2019, International Journal of Colorectal Disease.

[6]  W. Harmsen,et al.  Biologics and 30-Day Postoperative Complications After Abdominal Operations for Crohn's Disease: Are There Differences in the Safety Profiles? , 2019, Diseases of the colon and rectum.

[7]  Ionut Negoi,et al.  Preoperative factors associated with prolonged postoperative in-hospital length of stay in patients with Crohn’s disease undergoing intestinal resection or strictureplasty , 2019, International Journal of Colorectal Disease.

[8]  P. Higgins,et al.  415a – Anti-Tumor Necrosis Factor Therapy is Not Associated with Post-Operative Infection: Results from Prospective Cohort of Ulcerative Colitis and Crohn's Disease Patients Undergoing Surgery to Identify Risk Factors for Postoperative Infection I (Puccini) , 2019, Gastroenterology.

[9]  J. Barrio,et al.  Perioperative management and early complications after intestinal resection with ileocolonic anastomosis in Crohn’s disease: analysis from the PRACTICROHN study , 2019, Gastroenterology report.

[10]  J. Feuerstein,et al.  Surgery in the age of biologics , 2019, Gastroenterology report.

[11]  S. Vermeire,et al.  The operative risk and natural history after the diagnosis of ileal penetrating Crohn’s disease , 2018, European journal of gastroenterology & hepatology.

[12]  K. Alavi,et al.  Current trends and challenges in the postoperative medical management of Crohn's disease: A systematic review. , 2017, American journal of surgery.

[13]  A. Forbes,et al.  ESPEN guideline: Clinical nutrition in inflammatory bowel disease. , 2017, Clinical nutrition.

[14]  X. Jouven,et al.  Postoperative Complications after Ileocecal Resection in Crohn’s Disease: A Prospective Study From the REMIND Group , 2017, The American Journal of Gastroenterology.

[15]  S. Danese,et al.  Risk factors for complications after ileocolonic resection for Crohn’s disease with a major focus on the impact of preoperative immunosuppressive and biologic therapy: A retrospective international multicentre study , 2016, United European gastroenterology journal.

[16]  M. Mittlböck,et al.  Minimal-invasive approach for penetrating Crohn’s disease is not associated with increased complications , 2016, Surgical Endoscopy.

[17]  E. Louis,et al.  Anti-TNF Monotherapy for Crohn's Disease: a 13-year Multicentre Experience. , 2016, Journal of Crohn's & colitis.

[18]  O. Zmora,et al.  The effect of pre-operative optimization on post-operative outcome in Crohn’s disease resections , 2016, International Journal of Colorectal Disease.

[19]  Yifan Sun,et al.  Risk factors for postoperative intra-abdominal septic complications after surgery in Crohn's disease: A meta-analysis of observational studies. , 2015, Journal of Crohn's & colitis.

[20]  B. Cohen,et al.  A Review of the Impact of Biologics on Surgical Complications in Crohn's Disease , 2015, Inflammatory bowel diseases.

[21]  Jie-shou Li,et al.  Role of Exclusive Enteral Nutrition in the Preoperative Optimization of Patients With Crohn's Disease Following Immunosuppressive Therapy , 2015, Medicine.

[22]  T. Øresland,et al.  Surgery in the age of biological treatment , 2015, Scandinavian journal of gastroenterology.

[23]  S. Danese,et al.  Review article: optimal preparation for surgery in Crohn's disease , 2014, Alimentary pharmacology & therapeutics.

[24]  U. Ali,et al.  Impact of Preoperative Immunosuppressive Agents on Postoperative Outcomes in Crohn’s Disease , 2014, Diseases of the colon and rectum.

[25]  A. Steinhart,et al.  The Impact of Surgeon Volume on Postoperative Outcomes After Surgery for Crohn's Disease , 2014, Inflammatory bowel diseases.

[26]  Z. Cohen,et al.  Outcomes following surgery for perforating Crohn's disease , 2013, The British journal of surgery.

[27]  Sanjay V. Patel,et al.  Laparoscopic surgery for Crohn’s disease: a meta-analysis of perioperative complications and long term outcomes compared with open surgery , 2013, BMC Surgery.

[28]  H. Tulchinsky,et al.  Positive Histological Inflammatory Margins Are Associated With Increased Risk for Intra-abdominal Septic Complications in Patients Undergoing Ileocolic Resection for Crohn’s Disease , 2012, Diseases of the colon and rectum.

[29]  A. Kanazawa,et al.  Risk Factors for Postoperative Intra-abdominal Septic Complications after Bowel Resection in Patients with Crohn’s Disease , 2012, Diseases of the colon and rectum.

[30]  M. Silverberg,et al.  Preoperative biological therapy and short-term outcomes of abdominal surgery in patients with inflammatory bowel disease , 2012, Gut.

[31]  E. Consten,et al.  Early complications after stoma formation: a prospective cohort study in 100 patients with 1-year follow-up , 2012, International Journal of Colorectal Disease.

[32]  D. Hahnloser,et al.  Complications in colorectal surgery: risk factors and preventive strategies , 2010, Patient safety in surgery.

[33]  K. Van Steen,et al.  Long-term outcome of treatment with infliximab in 614 patients with Crohn’s disease: results from a single-centre cohort , 2008, Gut.

[34]  J. Church,et al.  Use of Infliximab within 3 Months of Ileocolonic Resection is Associated with Adverse Postoperative Outcomes in Crohn’s Patients , 2008, Journal of Gastrointestinal Surgery.

[35]  A. Hasted,et al.  Results of a nationwide prospective audit of stoma complications within 3 weeks of surgery , 2007, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[36]  A. Pierro,et al.  A systematic review of the impact of volume of surgery and specialization on patient outcome , 2007, The British journal of surgery.

[37]  E. Vicaut,et al.  Risk Factors for Intra-Abdominal Septic Complications After a First Ileocecal Resection for Crohn’s Disease: A Multivariate Analysis in 161 Consecutive Patients , 2007, Diseases of the colon and rectum.

[38]  D. Gouma,et al.  Laparoscopic-Assisted Versus Open Ileocolic Resection for Crohn's Disease: A Randomized Trial , 2006, Annals of surgery.

[39]  W. Harmsen,et al.  Early Postoperative Complications are not Increased in Patients with Crohn's Disease Treated Perioperatively with Infliximab or Immunosuppressive Therapy , 2004, American Journal of Gastroenterology.

[40]  P. Rutgeerts,et al.  The risk of post‐operative complications associated with infliximab therapy for Crohn's disease: a controlled cohort study , 2004, Alimentary pharmacology & therapeutics.

[41]  J. Lewis,et al.  Corticosteroids and immunomodulators: postoperative infectious complication risk in inflammatory bowel disease patients. , 2003, Gastroenterology.

[42]  M. Andersson,et al.  Preoperative management is more important than choice of sutured or stapled anastomosis in Crohn's disease. , 2002, The European journal of surgery = Acta chirurgica.

[43]  M. Keighley,et al.  Risk factors for intra-abdominal sepsis after surgery in Crohn's disease , 2000, Diseases of the colon and rectum.

[44]  J. Rombeau,et al.  Preoperative total parenteral nutrition and surgical outcome in patients with inflammatory bowel disease. , 1982, American journal of surgery.